Suppr超能文献

基于二次谐波产生技术鉴定无活性的构象选择性白细胞介素-2诱导型T细胞激酶(ITK)抑制剂

Identification of inactive conformation-selective interleukin-2-inducible T-cell kinase (ITK) inhibitors based on second-harmonic generation.

作者信息

Hantani Yoshiji, Iio Kiyosei, Hantani Rie, Umetani Kayo, Sato Toshihiro, Young Tracy, Connell Katelyn, Kintz Sam, Salafsky Joshua

机构信息

Biological/Pharmacological Research Laboratories Central Pharmaceutical Research Institute Japan Tobacco Inc. Takatsuki Osaka Japan.

Chemistry Research Laboratories Central Pharmaceutical Research Institute Japan Tobacco Inc. Takatsuki Osaka Japan.

出版信息

FEBS Open Bio. 2018 Jul 30;8(9):1412-1423. doi: 10.1002/2211-5463.12489. eCollection 2018 Sep.

Abstract

Many clinically approved protein kinase inhibitors stabilize an inactive conformation of their kinase target. Such inhibitors are generally highly selective compared to active conformation inhibitors, and consequently, general methods to identify inhibitors that stabilize an inactive conformation are much sought after. Here, we have applied a high-throughput, second-harmonic generation (SHG)-based conformational approach to identify small molecule stabilizers of the inactive conformation of interleukin-2-inducible T-cell kinase (ITK). A single-site cysteine mutant of the ITK kinase domain was created, labeled with an SHG-active dye, and tethered to a supported lipid bilayer membrane. Fourteen tool compounds, including stabilizers of the inactive and active conformations as well as nonbinders, were first examined for their effect on the conformation of the labeled ITK protein in the SHG assay. As a result, inactive conformation inhibitors were clearly distinguished from active conformation inhibitors by the intensity of SHG signal. Utilizing the SHG assay developed with the tool compounds described above, we identified the mechanism of action of 22 highly selective, inactive conformation inhibitors within a group of 105 small molecule inhibitors previously identified in a high-throughput biochemical screen. We describe here the first use of SHG for identifying and classifying inhibitors that stabilize an inactive vs. an active conformation of a protein kinase, without the need to determine costructures by X-ray crystallography. Our results suggest broad applicability to other proteins, particularly with single-site labels reporting on specific protein movements associated with selectivity.

摘要

许多临床批准的蛋白激酶抑制剂可稳定其激酶靶点的非活性构象。与活性构象抑制剂相比,此类抑制剂通常具有高度选择性,因此,人们一直在寻找鉴定稳定非活性构象抑制剂的通用方法。在此,我们应用了一种基于高通量二次谐波产生(SHG)的构象方法来鉴定白细胞介素-2诱导型T细胞激酶(ITK)非活性构象的小分子稳定剂。构建了ITK激酶结构域的单点半胱氨酸突变体,用SHG活性染料标记,并连接到支持的脂质双分子层膜上。首先在SHG分析中检测了14种工具化合物,包括非活性和活性构象的稳定剂以及非结合剂,以考察它们对标记的ITK蛋白构象的影响。结果,通过SHG信号强度可清楚地区分非活性构象抑制剂和活性构象抑制剂。利用上述工具化合物开发的SHG分析方法,我们在先前高通量生化筛选中鉴定出的105种小分子抑制剂中,确定了22种高选择性非活性构象抑制剂的作用机制。我们在此描述了首次使用SHG来鉴定和分类稳定蛋白激酶非活性与活性构象的抑制剂,而无需通过X射线晶体学确定共结构。我们的结果表明该方法对其他蛋白质具有广泛适用性,特别是对于通过单点标记报告与选择性相关的特定蛋白质运动的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/df80ff2bcaaa/FEB4-8-1412-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验